PER-8, a Novel Extended-Spectrum β-Lactamase PER Variant, from an Acinetobacter baumannii Clinical Isolate in Nepal

Tatsuya Tada1, Shovita Shrestha2, Kayo Shimada1

  • 1Department of Infectious Diseases, Research Institute, National Center for Global Health and Medicine, Tokyo, Japan.

Insights

A new extended-spectrum beta-lactamase, PER-8, was found in Acinetobacter baumannii. This enzyme shows altered activity against specific antibiotics, posing new challenges for treatment.

Area of Science:

  • Microbiology
  • Molecular Biology
  • Antimicrobial Resistance

Background:

  • Extended-spectrum beta-lactamases (ESBLs) are a significant cause of antibiotic resistance in Gram-negative bacteria.
  • Acinetobacter baumannii is an opportunistic pathogen frequently associated with hospital-acquired infections and multidrug resistance.
  • The PER-type ESBLs are a class of beta-lactamases that confer resistance to a broad range of beta-lactam antibiotics.

Purpose of the Study:

  • To identify and characterize a novel PER-type extended-spectrum beta-lactamase (ESBL) from a clinical isolate of Acinetobacter baumannii.
  • To investigate the biochemical properties and substrate specificity of the newly identified PER-8 enzyme.
  • To analyze the genetic context and plasmid-mediated dissemination potential of the blaPER-8 gene.

Main Methods:

  • Isolation and identification of Acinetobacter baumannii from a clinical sample.
  • Molecular characterization of the novel beta-lactamase gene (blaPER-8) using sequencing.
  • Biochemical assays to determine kinetic parameters (kcat/K) for various beta-lactam substrates, including aztreonam and imipenem.
  • Analysis of the surrounding genetic elements and plasmid structure harboring the blaPER-8 gene.

Main Results:

  • A novel PER-type ESBL, designated PER-8, was identified in an Acinetobacter baumannii clinical isolate from Nepal.
  • PER-8 differs from PER-7 by a single amino acid substitution (Glycine to Glutamic acid at position 39).
  • PER-8 exhibited reduced catalytic efficiency (kcat/K) against aztreonam but increased efficiency against imipenem compared to PER-7.
  • The blaPER-8 gene was located within a complex genetic structure (intI1 blaPSE-1 qacEDI sulI ISCR1-blaPER-8 gts sulI orfX) on a 100-kb plasmid.

Conclusions:

  • The identification of PER-8 highlights the ongoing evolution of ESBLs in Acinetobacter baumannii.
  • The altered substrate profile of PER-8 may impact treatment strategies for infections caused by resistant strains.
  • The plasmid-borne nature and complex genetic environment of blaPER-8 suggest potential for horizontal gene transfer and spread.